» Articles » PMID: 36611449

Performance of Deauville Criteria in FDG-PET/CT Diagnostics of Giant Cell Arteritis

Overview
Specialty Radiology
Date 2023 Jan 8
PMID 36611449
Authors
Affiliations
Soon will be listed here.
Abstract

In this retrospective study, PET/CT data from 59 patients with suspected giant cell arteritis (GCA) were reviewed using the Deauville criteria to determine an optimal cut-off between PET positivity and negativity. Seventeen standardised vascular regions were analysed per patient by three investigators blinded to clinical information. Statistical analysis included ROC curves with areas under the curve (AUC), Cohen's and Fleiss' kappa (κ) to calculate sensitivity, specificity, accuracy, and agreement. According to final clinician's diagnosis and the revised 2017 ACR criteria GCA was confirmed in 29 of 59 (49.2 %) patients. With a diagnostic cut-off ≥ 4 (highest tracer uptake of a vessel wall exceeds liver uptake) for PET positivity, all investigators achieved high accuracy (range, 89.8-93.2%) and AUC (range, 0.94-0.97). Sensitivity and specificity ranged from 89.7-96.6% and 83.3-96.7%, respectively. Agreement between the three investigators suggested 'almost perfect agreement' (Fleiss' κ = 0.84) A Deauville score of ≥4 as threshold for PET positivity yielded excellent results with high accuracy and almost perfect inter-rater agreement, suggesting a standardized, reproducible, and reliable score in diagnosing GCA. However, the small sample size and reference standard could lead to biases. Therefore, verification in a multicentre study with a larger patient cohort and prospective setting is needed.

References
1.
Kobe C, Goergen H, Baues C, Kuhnert G, Voltin C, Zijlstra J . Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma. Blood. 2018; 132(21):2273-2279. DOI: 10.1182/blood-2018-05-852129. View

2.
Barraclough K, Mallen C, Helliwell T, Hider S, Dasgupta B . Diagnosis and management of giant cell arteritis. Br J Gen Pract. 2012; 62(599):329-30. PMC: 3361116. DOI: 10.3399/bjgp12X649313. View

3.
Kung B, Seraj S, Zirakchian Zadeh M, Rojulpote C, Kothekar E, Ayubcha C . An update on the role of F-FDG-PET/CT in major infectious and inflammatory diseases. Am J Nucl Med Mol Imaging. 2020; 9(6):255-273. PMC: 6971480. View

4.
Blomberg B, Thomassen A, Takx R, Hildebrandt M, Simonsen J, Buch-Olsen K . Delayed ¹⁸F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: results from the CAMONA study. J Nucl Cardiol. 2014; 21(3):588-97. DOI: 10.1007/s12350-014-9884-6. View

5.
Sugawara Y, Gutowski T, Fisher S, Brown R, Wahl R . Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, 67Ga-citrate, and 125I-HSA. Eur J Nucl Med. 1999; 26(4):333-41. DOI: 10.1007/s002590050395. View